Increased VLDL-apoB and IDL-apoB production rates in nonlipodystrophic HIV-infected patients on a protease inhibitor-containing regimen

This publication has 33 references indexed in Scilit:

• Role of Long-Term Nucleoside-Analogue Therapy in Lipodystrophy and Metabolic Disorders in Human Immunodeficiency Virus--Infected Patients
  Clinical Infectious Diseases, 2002
• Association Between Insulin Resistance and Hepatitis C Virus Chronic Infection in HIV–Hepatitis C Virus–Coinfected Patients Undergoing Antiretroviral Therapy
  JAIDS Journal of Acquired Immune Deficiency Syndromes, 2001
• Metabolic Abnormalities and Cardiovascular Disease Risk Factors in Adults with Human Immunodeficiency Virus Infection and Lipodystrophy
  Clinical Infectious Diseases, 2001
• HIV-1 Protease Inhibitors Induce an Increase of Triglyceride Level in HIV-Infected Men Without Modification of Insulin Sensitivity: A Longitudinal Study
  Hormone and Metabolic Research, 2000
• Hyperlipidemia and Insulin Resistance Are Induced by Protease Inhibitors Independent of Changes in Body Composition in Patients With HIV Infection
  JAIDS Journal of Acquired Immune Deficiency Syndromes, 2000
• Adverse effects of reverse transcriptase inhibitors
  AIDS, 1998
• Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus Infection
  New England Journal of Medicine, 1998
• Decrease of HIV-1 RNA levels in lymphoid tissue and peripheral blood during treatment with ritonavir, lamivudine and zidovudine
  AIDS, 1998
• Lipids, lipoproteins, triglyceride clearance, and cytokines in human immunodeficiency virus infection and the acquired immunodeficiency syndrome
  Journal of Clinical Endocrinology & Metabolism, 1992
• Atherogenesis: a postprandial phenomenon.
  Circulation, 1979